Alzokaky AA et al (2023) Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice. Life Sci 316:121390

Article  CAS  PubMed  Google Scholar 

Amaral NB et al (2023) Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients. Inflamm Res off J Eur Histamine Res Soc 72(5):895–899

CAS  Google Scholar 

Amin FM, Shehatou GSG, Nader MA, Abdelaziz RR (2023) Piperine mitigates aortic vasculopathy in streptozotocin-diabetic rats via targeting TXNIP-NLRP3 signaling. Life Sci 314:121275

Article  CAS  PubMed  Google Scholar 

Arab HH, Ashour AM, Gad AM, Mahmoud AM, Kabel AM (2021) Activation of AMPK/mTOR-driven autophagy and inhibition of NLRP3 inflammasome by saxagliptin ameliorate ethanol-induced gastric mucosal damage. Life Sci 280:119743

Article  CAS  PubMed  Google Scholar 

Awad AM, Elshaer SL, Gangaraju R, Abdelaziz RR, Nader MA (2024) Ameliorative effect of montelukast against STZ induced diabetic nephropathy: targeting HMGB1, TLR4, NF-κB, NLRP3 inflammasome, and autophagy pathways. Inflammopharmacology 32(1):495–508

Article  CAS  PubMed  Google Scholar 

Birnbaum Y, Bajaj M, Qian J, Ye Y (2016) Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome. BMJ Open Diabetes Res & Care 4(1):e000227

Article  Google Scholar 

Birnbaum Y, Tran D, Bajaj M, Ye Y (2019) DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome. Basic Res Cardiol 114(5):35

Article  PubMed  Google Scholar 

Cai J et al (2021) NLRP3 inflammasome mediated pyroptosis is involved in cadmium exposure-induced neuroinflammation through the IL-1β/IkB-α-NF-κB-NLRP3 feedback loop in swine. Toxicology 453:152720

Article  CAS  PubMed  Google Scholar 

Chen H et al (2020) Identification of NLRP3 inflammation-related gene promoter hypomethylation in diabetic retinopathy. Invest Ophthalmol vis Sci 61(13):12

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen H, Tran D, Yang H-C, Nylander S, Birnbaum Y, Ye Y (2020a) Dapagliflozin and ticagrelor have additive effects on the attenuation of the activation of the NLRP3 inflammasome and the progression of diabetic cardiomyopathy: an AMPK–mTOR interplay. Cardiovasc Drugs Ther 34(4):443–461

Article  CAS  PubMed  Google Scholar 

Chen Y et al (2020b) Discovery and optimization of 4-oxo-2-thioxo-thiazolidinones as NOD-like receptor (NLR) family, pyrin domain-containing protein 3 (NLRP3) inhibitors. Bioorg Med Chem Lett 30(7):127021

Article  CAS  PubMed  Google Scholar 

Chen W et al (2022) The upregulation of NLRP3 inflammasome in dorsal root ganglion by ten-eleven translocation methylcytosine dioxygenase 2 (TET2) contributed to diabetic neuropathic pain in mice. J Neuroinflammation 19(1):302

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen L-C et al (2023) Inactivation of mitochondrial pyruvate carrier promotes NLRP3 inflammasome activation and gout development via metabolic reprogramming. Immunology 169(3):271–291

Article  CAS  PubMed  Google Scholar 

Chen Y et al (2024) MSC-derived small extracellular vesicles alleviate diabetic retinopathy by delivering miR-22-3p to inhibit NLRP3 inflammasome activation. Stem Cells 42(1):64–75

Article  PubMed  Google Scholar 

Chiazza F et al (2015) Targeting the NLRP3 inflammasome to Reduce Diet-induced Metabolic Abnormalities in Mice. Mol Med 21(1):1025–1037

Article  CAS  Google Scholar 

Chinta PK, Tambe S, Umrani D, Pal AK, Nandave M (2022) Effect of parthenolide, an NLRP3 inflammasome inhibitor, on insulin resistance in high-fat diet-obese mice. Can J Physiol Pharmacol 100(3):272–281

Article  CAS  PubMed  Google Scholar 

Chung I-C et al (2019) Pretreatment with a heat-killed probiotic modulates the NLRP3 inflammasome and attenuates colitis-associated colorectal cancer in mice. Nutrients. https://doi.org/10.3390/nu11030516

Article  PubMed  PubMed Central  Google Scholar 

Dai Y, Dai D, Wang X, Ding Z, Mehta JL (2014) DPP-4 inhibitors repress NLRP3 Inflammasome and Interleukin-1beta via GLP-1 receptor in macrophages through protein Kinase C pathway. Cardiovasc Drugs Ther 28(5):425–432

Article  CAS  PubMed  Google Scholar 

Dai X et al (2021) Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy. Redox Biol 45:102033

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dapueto R et al (2021) A novel nitroalkene vitamin E analogue inhibits the NLRP3 inflammasome and protects against inflammation and glucose intolerance triggered by obesity. Redox Biol 39:101833

Article  CAS  PubMed  Google Scholar 

Deng B, Hu Y, Sheng X, Zeng H, Huo Y (2020) miR-223-3p reduces high glucose and high fat-induced endothelial cell injury in diabetic mice by regulating NLRP3 expression. Exp Ther Med 20(2):1514–1520

Article  CAS  PubMed  PubMed Central  Google Scholar 

Derosa G, Maffioli P (2012) α-Glucosidase inhibitors and their use in clinical practice. Arch Med Sci 8(5):899–906

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding H et al (2021) MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome. Mol Ther 29(7):2308–2320

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong T, Huang D, Jin Z (2024) Mechanism of sodium butyrate, a metabolite of gut microbiota, regulating cardiac fibroblast transdifferentiation via the NLRP3/Caspase-1 pyroptosis pathway. J Cardiothorac Surg 19(1):208

Article  PubMed  PubMed Central  Google Scholar 

Drucker DJ (2018) Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab 27(4):740–756

Article  CAS  PubMed  Google Scholar 

Dwivedi DK, Jena GB (2023) Dimethyl fumarate-mediated Nrf2/ARE pathway activation and glibenclamide-mediated NLRP3 inflammasome cascade inhibition alleviate type II diabetes-associated fatty liver in rats by mitigating oxidative stress and inflammation. J Biochem Mol Toxicol 37(7):e23357

Article  CAS  PubMed  Google Scholar 

El-Rous MA, Saber S, Raafat EM, Ahmed AAE (2021) Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NFκB/AMPK/NLRP3 axis. Inflammopharmacology 29(4):1169–1185

Article  CAS  PubMed  Google Scholar 

ElSayed MH et al (2023) Memantine mitigates ROS/TXNIP/NLRP3 signaling and protects against mouse diabetic retinopathy: histopathologic, ultrastructural and bioinformatic studies. Biomed Pharmacother 163:114772

Article  CAS  PubMed  Google Scholar 

El-Shaer NO, Hegazy AM, Muhammad MH (2023) Protective effect of quercetin on pulmonary dysfunction in streptozotocin-induced diabetic rats via inhibition of NLRP3 signaling pathway. Environ Sci Pollut Res 30(14):42390–42398

Article  CAS  Google Scholar 

Escartín-Gutiérrez JR, Ponce-Figueroa M, Torres-Vega MÁ, Aguilar-Faisal L, Figueroa-Arredondo P (2023) Transcriptional activation of a pro-inflammatory response (NF-κB, AP-1, IL-1β) by the Vibrio cholerae cytotoxin (VCC) MONOMER THROUGH the MAPK signaling pathway in the thp-1 human macrophage cell line. Int J Mol Sci. https://doi.org/10.3390/ijms24087272

Article  PubMed  PubMed Central  Google Scholar 

Faghfouri AH et al (2022) Regulation of NLRP3 inflammasome by zinc supplementation in Behçet’s disease patients: a double-blind, randomized placebo-controlled clinical trial. Int Immunopharmacol 109:108825